Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Radiodermatitis 1 Melanoma 1 Immune System Diseases 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 8 fludarabine phosphate 6 fludarabine 5 Bendamustine Hydrochloride 4 Busulfan 3 AP 1903 reagent 3 pembrolizumab 2 Tacrolimus 2 Mycophenolic Acid 2 thymoglobulin 1 pimonidazole 1 palbociclib 1 ibritumomab tiuxetan 1 Valsartan 1 Telemedicine 1 Surveys and Questionnaires 1 Rivaroxaban 1 Rituximab 1 Radiotherapy 1 Plasmalyte A 1 Pharmacogenomic Testing 1 Melphalan 1 Hydroxychloroquine 1 Etoposide 1 Dimethyl Sulfoxide 1 Cytarabine 1 Carmustine 1 Bone Marrow Transplantation 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Immune System Diseases × Dimethyl Sulfoxide × Clear all

NCT02519816 2019-08-14

CARE

Maisonneuve-Rosemont Hospital

Phase 2 Unknown

Immune System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡